- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – ...

INB-200 is well-tolerated, showing no serious toxicities beyond those typically observed with chemotherapy. Importantly no ...

TURKU, FI / ACCESS Newswire / June 2, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Favorable response rates and survival data in high/very high-risk frontline and r/r MDS support advancement ...